A postdoctoral position is immediately available in the laboratory of Dr. Ken H. Young in the Department of Pathology at Duke University Medical Center and Duke Cancer Institute. The Young lab focuses on clinical and pathologic translational studies in lymphoma and myeloma and has assessed a number of genetic and epigenetic biomarkers for prognostic and therapeutic importance in blood cancer (examples include PMID 34980601, 30745366, 33148342, 31640780, 31127191, 27760757, 23449635, 23982177, 22955915, etc). The current position is to investigate treatment resistance mechanisms and novel therapeutic approaches in lymphoma using molecular and proteomic technologies. We are seeking a highly motivated postdoctoral candidate with strong background in cellular, molecular and/or immunology for this position. Future promotion is available for those excellent and dedicative individuals.
Qualifications:
- PhD, MD/PhD or equivalent degree in cancer biology, cellular and molecular biology, biochemistry, pathology, pharmaceutical sciences, immunology, or related fields.
- Experience and expertise in cell culture, molecular techniques, and data analysis.
- A good record of publications in peer-reviewed journals.
- Good time management skills for high productivity. Ability to design and perform functional studies will be plus.
To submit, please send a cover letter describing your research experience and interests, a CV, and three references by email to Dr. Ken H. Young at ken.young@duke.edu and Dr. Xu-Monette at zijun.xumonette@duke.edu.